InvestorsHub Logo
Followers 5
Posts 280
Boards Moderated 0
Alias Born 09/16/2014

Re: None

Tuesday, 08/11/2015 1:31:06 AM

Tuesday, August 11, 2015 1:31:06 AM

Post# of 113951
FONR 2 snippets I wanted to share. Someone on the yahoo board mentioned it may be down due to fear about Medicare reimbursement cuts. Turns out in the 2016 proposed rule (released July 8 for final rules to be released Nov 1 to take effect Jan 1, 2017) the combined effect of the new rules on "allowed charges" for diagnostic imaging centers, like FONR's, would be +1%.* That sure seems like it covers FONR. Remember I am treating their non-profit medical device business as an advertising wing of their management business. Funny thing is they just about say the same thing in their last 10-K.

Also did anyone else notice they spent $1.1M on buying out NCI in one of their subs in May on top of the $5M in Jan? Those are great transactions IMO. It's hard to tell but from comparing financials it seems they are paying about 10X pretax for the additional cash flow from the NCI, a good deal, especially since they have NOLs to use.

My rough DCFA is saying they are selling for about their no-growth value without the NOLs and should be worth $14-15 depending on how you value the NOLs (i.e. how fast they realize their value & how you discount it to present). Also they have an easy path to earnings growth by spending their next $2m on buying out NCI, which would increase earnings by something like 20%. I already have about as much as I can buy with an average in the $9.8s.

Good Luck all.

As always this is not investment advice, but some teasers to get people interested to do their own research.

*Source (Table 45): https://www.federalregister.gov/articles/2015/07/15/2015-16875/medicare-program-revisions-to-payment-policies-under-the-physician-fee-schedule-and-other-revisions

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.